|
|
 |
| |
|
Home > Drug Companies > Prometheus
Prometheus
Prometheus Laboratories Inc. is a specialty pharmaceutical company committed to developing new ways to help physicians individualize patient care. The Company focuses on the treatment, diagnosis and detection of gastrointestinal, autoimmune and inflammatory diseases and disorders.
The firm is a specialty pharmaceutical company committed to developing new ways to help physicians individualize patient care and is built upon a foundation of successful relationships with physician specialists. They market and deliver proprietary, high value diagnostic testing services which complement the company's pharmaceutical products.
Their diagnostics include non-invasive testing to help expedite difficult diagnoses. Their products provide pharmacogenetic evaluations, which assist in therapy management. Their services also enable metabolism based dosing to further individualize treatment.
The firm integrates therapeutics and clinical information services for the optimal management of chronic and challenging diseases. Through this integration, they address the continuum of patient care, from early disease detection, differentiation, and diagnosis, to therapeutic intervention to disease and therapy monitoring. Their paradigm is engineered to provide patients with individualized care by assisting physicians with rapid diagnosis and optimal treatment.
Prometheus offers products for select specialties, including Gastroenterology and Rheumatology. By maintaining a focus in select specialties, Prometheus is able to serve as a technically competent, consultative partner to involved physician specialists. The firm is committed to helping physicians personalize patient management with serodiagnostic evaluation to detect chronic and challenging conditions, and therapy management tools to further customize patient treatment.
The Prometheus is committed to developing new ways of personalizing patient care integrating therapeutics and diagnostics. Their goal is to continue to evolve this model, providing the information and tools necessary to treat patients throughout the healthcare continuum, from diagnosis and treatment to response monitoring. By advancing this paradigm, they expect to help physicians increase the efficacy, speed, and cost efficiency of patient care.
Back to Drug Companies
|
|
|
|
|
|
|
|